Article Details

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased ... - TradingView

Retrieved on: 2024-09-30 19:10:16

Tags for this article:

Click the tags to see associated articles and topics

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased ... - TradingView. View article details on hiswai:

Excerpt

Truist Securities raised the price target for Corcept Therapeutics Incorporated NASDAQ:CORT and cites continued momentum in Korlym sales more than ...

Article found on: www.tradingview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up